Id Counterfeit Pharmaceuticals with Portable Raman
Rigaku
AAPS 2012 in Chicago
in-Pharmatechnologist.com breezed into Chicago, the windy city, for the American Association of Pharmaceutical Scientists' (AAPS) annual conference. We spoke with some of the drug industry's thought leaders and tracked down all the breaking news.
News from AAPS
Xcelience plans EU clinical trial supply expansion after opening new US plant
23-Oct-2012 - Xcelience is shopping for a European distributor after opening a new clinical trial supply facility in the US.
News from AAPS
Low API and excipient volumes vital to win authorisation under EU PIP says EMA
23-Oct-2012 - Pharmas should use lower API and excipient volumes if seeking authorisation under the EU Paediatric Investigation Plan (PIP) says the EMA.
update - audio available
Catalent says sharing with industry will not dull competetive edge
22-Oct-2012 - Catalent says making its technology available to industry will not affect its competitive edge.
News in brief
Catalent aims to boost drug delivery through industry-academia partnership
18-Oct-2012 - Catalent has established a new institute in a bid to advance drug delivery by creating links between industry and academia.
Disptaches from AAPS
Eliminate scale up by using R&D equipment for commercial production: GSK
18-Oct-2012 - Using the same equipment from R&D to scale up will cut costs, time and improve efficiency, according to GSK.
Dispatches from AAPS
Capsugel expands liquid fill capsule capabilities
17-Oct-2012 - Capsugel has expanded its Licaps liquid fill capsule line with a new facility in the US.
Dispatches from AAPS
Bend Research hunting new partnerships to boost bioavailability offering
17-Oct-2012 - Bend Research is “actively” hunting new partnerships similar to its recent alliance with Dow.
Dispatches from AAPS
Remember regional Biosimilar regs and ref drugs differ, says Pfizer
16-Oct-2012 - Manufacturers trying to prove the similarity of their biosimilars must consider that regulations and reference medicines differ in different markets says Pfizer.
Dispatches from AAPS
Emerging market CMOs and their customers must make info easily available: FDA
16-Oct-2012 - Make information about generic production readily available when working with vendors in emerging markets for quicker US approval, says the FDA.
Dispatches from AAPS
Peru's GMP requirements mean delayed approvals, says expert
16-Oct-2012 - Stricter GMP requirements in Peru are increasing the time it takes to get drugs approved and may not be giving regulators any useful additional information.
Most Popular News
Key Industry Events
Products
On demand Supplier Webinars
Discover innovative single-use mixer for efficient mixing of low shear and particulate sensitive solutions in cGMP environment
ATMI Life Science
ATMI Life Science
